Neuropathix, Inc. – OTC:NPTX

Neuropathix stock price today

$0
Financial Health
0
1
2
3
4
5
6
7
8
9

Neuropathix stock price monthly change

-100.00%
month

Neuropathix stock price quarterly change

-100.00%
quarter

Neuropathix stock price yearly change

-100.00%
year

Neuropathix key metrics

Market Cap
 18.76K
Enterprise value
 2.04M
P/E
 -0.01
EV/Sales
 5.68
EV/EBITDA
 -0.64
Price/Sales
 0.10
Price/Book
 N/A
PEG ratio
 N/A
EPS
 -0.04
Revenue
 N/A
EBITDA
 -1.24M
Income
 -4.12M
Revenue Q/Q
 549.93%
Revenue Y/Y
 1023.30%
Profit margin
 -1064.05%
Oper. margin
 -618.48%
Gross margin
 0%
EBIT margin
 -618.48%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Neuropathix stock price history

Neuropathix stock forecast

Neuropathix financial statements

Profit Margin

Neuropathix, Inc. (OTC:NPTX): Profit margin
Jun 2021 0 -751.12K
Sep 2021 0 -721.33K
Dec 2021 151.47K -756.75K -499.59%
Mar 2022 207.98K -1.90M -913.63%
NPTX income statement history

Debt to Assets

Neuropathix, Inc. (OTC:NPTX): Debt to assets
Jun 2021 160668 3.35M 2086.51%
Sep 2021 149432 3.66M 2452.07%
Dec 2021 224703 4.21M 1874.23%
Mar 2022 387353 5.63M 1455.76%
NPTX balance sheet history

Cash Flow

Neuropathix, Inc. (OTC:NPTX): Cash Flow
Jun 2021 -269.85K -6.52K 4.21K
Sep 2021 -142.90K 0 97.48K
Dec 2021 -30.99K 8.1K 32.97K
Mar 2022 -113.67K 0 200.19K
NPTX cash flow history

Neuropathix alternative data

Neuropathix
Employees

Neuropathix, Inc. (OTC:NPTX): Employee count
Aug 2023 6
Sep 2023 6
Oct 2023 6
Nov 2023 6
Dec 2023 6
Jan 2024 6
Feb 2024 6
Mar 2024 6
Apr 2024 6
May 2024 6
Jun 2024 6
Jul 2024 6

Neuropathix other data

Neuropathix
Insider Trading

Neuropathix, Inc. (OTC:NPTX): Insider trades (number of shares)
Period Buy Sel
Jan 2022 0 250000
May 2022 0 180000
Jun 2022 0 320000
Transaction Date Insider Security Shares Price per share Total value Source
Sale
PETKANAS DEAN director, 10 percent owner, off..
 Common Stock 238,164 $0.02 $5,001
Sale
PETKANAS DEAN director, 10 percent owner, off..
 Common Stock 21,836 $0.02 $459
Sale
PETKANAS DEAN director, 10 percent owner, off..
 Common Stock 50,000 $0.02 $1,000
Sale
PETKANAS DEAN director, 10 percent owner, off..
 Common Stock 10,000 $0.03 $250
Sale
PETKANAS DEAN director, 10 percent owner, off..
 Common Stock 20,000 $0.03 $520
Sale
PETKANAS DEAN director, 10 percent owner, off..
 Common Stock 10,000 $0.03 $280
Sale
PETKANAS DEAN director, 10 percent owner, off..
 Common Stock 50,000 $0.03 $1,450
Sale
PETKANAS DEAN director, 10 percent owner, off..
 Common Stock 100,000 $0.03 $2,600
Sale
PETKANAS DEAN director, 10 percent owner, off..
 Common Stock 41,000 $0.05 $1,886
Sale
PETKANAS DEAN director, 10 percent owner, off..
 Common Stock 120,000 $0.05 $6,120
NPTX insider trading transactions

Frequently Asked Questions (FAQ)

  • What's the price of Neuropathix stock today?

    One share of Neuropathix stock can currently be purchased for approximately $0.

  • When is Neuropathix's next earnings date?

    Unfortunately, Neuropathix's (NPTX) next earnings date is currently unknown.

  • Does Neuropathix pay dividends?

    No, Neuropathix does not pay dividends.

  • How much money does Neuropathix make?

    Neuropathix has a market capitalization of 18.76K.

  • What is Neuropathix's stock symbol?

    Neuropathix, Inc. is traded on the OTC under the ticker symbol "NPTX".

  • What is Neuropathix's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of Neuropathix?

    Shares of Neuropathix can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does Neuropathix have?

    As Jul 2024, Neuropathix employs 6 workers.

  • When Neuropathix went public?

    Neuropathix, Inc. is publicly traded company for more then 4 years since IPO on 24 Dec 2020.

  • What is Neuropathix's official website?

    The official website for Neuropathix is neuropathix.com.

  • Where are Neuropathix's headquarters?

    Neuropathix is headquartered at Pennsylvania Biotechnology Center, Doylestown, PA.

  • How can i contact Neuropathix?

    Neuropathix's mailing address is Pennsylvania Biotechnology Center, Doylestown, PA and company can be reached via phone at 858 883 2642.

Neuropathix company profile:

Neuropathix, Inc.

neuropathix.com
Exchange:

OTC

Full time employees:

6

Industry:

Biotechnology

Sector:

Healthcare

Neuropathix, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics from its proprietary synthetic cannabinoid derivatives platform. It engages in the research and development of chemical entities, such as KLS-13019, KLS-13023, and KLS-13022, as well as its related molecules; and synthetic cannabidiol therapeutics through pre-clinical drug discovery and development processes for use in the disease indications of chemotherapy induced peripheral neuropathy, overt hepatic encephalopathy, mild traumatic brain injury, and chronic traumatic encephalopathy. The company was formerly known as Kannalife, Inc. and changed its name to Neuropathix, Inc. in November 2020. Neuropathix, Inc. was founded in 2010 and is based in Doylestown, Pennsylvania.

858 883 2642
Pennsylvania Biotechnology Center
Doylestown, PA 18902

CIK: 0001615999
ISIN: US64132Q1094
CUSIP: 64132Q109